Press "esc" to clear
Go to Advanced Search

Showing results

110 of 227
Embargo will expire:
21-Aug-2018 9:00 AM EDT
Released to reporters:
20-Aug-2018 9:00 AM EDT

EMBARGOED

A reporter's PressPass is required to access this story until the embargo expires on 21-Aug-2018 9:00 AM EDT

Article ID: 698695

First FDA-Approved Study of Focused Ultrasound to Open Blood-Brain Barrier

University of Maryland Medical Center/School of Medicine

In the first such clinical trial in the United States, physician-scientists with the University of Maryland School of Medicine (UMSOM) are investigating the use of MRI-guided focused ultrasound to open the blood-brain barrier. The trial will be conducted with patients undergoing brain cancer surgery at the University of Maryland Medical Center (UMMC).

Released:
9-Aug-2018 9:45 AM EDT
EXPERT AVAILABLE
Open in New Tab
Comment

Article ID: 695772

University of Maryland Greenebaum Comprehensive Cancer Center Partners with Nation's Top Cancer Centers to Endorse Goal of Eliminating HPV-Related Cancers in U.S.

University of Maryland Medical Center/School of Medicine

The University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center (UMGCCC) joins with 69 other National Cancer Institute (NCI)-designated cancer centers to urge increased vaccination for human papillomavirus (HPV) and screening to eliminate HPV-related cancers.

Released:
7-Jun-2018 1:00 PM EDT
EXPERT AVAILABLE
Open in New Tab
Comment

Article ID: 691277

University of Maryland Greenebaum Comprehensive Cancer Center Now Among Select Institutions Certified to Administer CAR T-Cell Therapy for Lymphoma

University of Maryland Medical Center/School of Medicine

The University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center (UMGCCC) is now certified to offer a groundbreaking treatment for non-Hodgkin lymphoma, in which a patient’s own immune cells are genetically engineered to recognize and attack the cancer.

Released:
19-Mar-2018 2:00 PM EDT
EXPERT AVAILABLE
Open in New Tab
Comment
3397-Eisenberg_Howard.jpg

Article ID: 689397

Pivotal Study of Focused Ultrasound to Treat Parkinson's Disease

University of Maryland Medical Center/School of Medicine

The University of Maryland Medical Center (UMMC) and the University of Maryland School of Medicine (UMSOM)) are leading a phase 3 study to test the safety and efficacy of using MRI-guided focused ultrasound on the brain in order to treat Parkinson’s disease. The pivotal study is the final step before the U.S. Food and Drug Administration (FDA) will consider approving the new technology for widespread use as a nonsurgical treatment option to eliminate key motor symptoms of this common neurological condition.

Released:
12-Feb-2018 4:15 PM EST
EXPERT AVAILABLE
Open in New Tab
Comment

Article ID: 688223

Novel Gene Mutations Link High HDL Cholesterol and Apparent Protection From Heart Disease

University of Maryland Medical Center/School of Medicine

Researchers at the University of Maryland School of Medicine have uncovered genetic mutations that may explain why people with high levels of high-density lipoprotein (HDL) cholesterol, the “good cholesterol,” have a reduced risk of coronary heart disease.

Released:
7-Feb-2018 10:00 AM EST
EXPERT AVAILABLE
Open in New Tab
Comment

Article ID: 687244

First Stereotactic Radiation Therapy System Designed to Treat Early Stage Breast Cancer Receives FDA Clearance

University of Maryland Medical Center/School of Medicine

The GammaPod ™ – a first-of-its kind stereotactic radiotherapy system to treat early stage breast cancer – has received 510(k) clearance from the U.S. Food and Drug Administration (FDA), paving the way for the manufacturer to bring the system to market for the treatment of breast cancer patients.

Released:
22-Dec-2017 4:00 PM EST
EXPERT AVAILABLE
Open in New Tab
Comment

Article ID: 686265

Study Uses Genetic Testing to Personalize Treatment for Deadly Blood Cancer

University of Maryland Medical Center/School of Medicine

A clinical trial using genetic testing to match acute myeloid leukemia (AML) patients with new therapies is now open at the University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center (UMGCCC). The center is one of seven cancer centers nationwide participating in the Beat AML® Master Trial, sponsored by the Leukemia & Lymphoma Society (LLS).

Released:
6-Dec-2017 11:15 AM EST
EXPERT AVAILABLE
Open in New Tab
Comment
Gilotra_Mohit1.JPG

Article ID: 685942

University of Maryland School of Medicine Orthopaedic Surgeons to Receive Prestigious International Research Award

University of Maryland Medical Center/School of Medicine

A research team led by Mohit N. Gilotra, MD, assistant professor of orthopaedics at the University of Maryland School of Medicine (UMSOM), will receive the prestigious 2018 Charles S. Neer Award from the American Shoulder and Elbow Surgeons (ASES) for a clinical study that demonstrated an effective method to potentially reduce the risk of serious infection following shoulder surgery.

Released:
30-Nov-2017 6:05 PM EST
EXPERT AVAILABLE
Open in New Tab
Comment
  • Embargo expired:
    27-Nov-2017 11:30 AM EST

Article ID: 685669

Scientists Identify Key Factors That Help Microbes Thrive In Harsh Environments

University of Maryland Medical Center/School of Medicine

Three new studies by University of Maryland School of Medicine scientists have identified key factors that help microbes survive in harsh environments.

Released:
22-Nov-2017 1:20 PM EST
EXPERT AVAILABLE
Open in New Tab
Comment

Showing results

110 of 227





Chat now!